These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 327583)

  • 1. Clinical experience with amikacin, a new aminoglycoside antibiotic.
    Theron FP; De Kock MA
    S Afr Med J; 1977 May; 51(21):746-8. PubMed ID: 327583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amikacin therapy for serious gram-negative infection.
    Pollock AA; Berger SA; Richmond AS; Simberkoff MS; Rahal JJ
    JAMA; 1977 Feb; 237(6):562-4. PubMed ID: 576282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amikacin therapy of infections in neutropenic patients.
    Valdivieso M; Feld R; Rodriguez V; Bodey GP
    Am J Med Sci; 1975; 270(3):453-63. PubMed ID: 1108649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gram negative bone and joint infection: sixty patients treated with amikacin.
    Schurman DJ; Wheeler R
    Clin Orthop Relat Res; 1978; (134):268-74. PubMed ID: 365414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
    Jeljaszewicz J; Włodarczak K; Bis W; Kazanowski A; Kuzniewski P; Molska J
    Zentralbl Bakteriol A; 1980 Aug; 247(3):347-52. PubMed ID: 6999802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amikacin for treatment of infections in patients with malignant diseases.
    Bodey GP; Rodriguez V; Valdivieso M; Feld R
    J Infect Dis; 1976 Nov; 134 SUPPL():S421-7. PubMed ID: 993633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
    Sklaver AR; Greenman RL; Hoffman TA
    Arch Intern Med; 1978 May; 138(5):713-6. PubMed ID: 348135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms.
    Tally FP; Louie TJ; Weinstein WM; Bartlett JG; Gorbach SL
    Ann Intern Med; 1975 Oct; 83(4):484-8. PubMed ID: 1101761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Our experience with amikacin. Preliminary observations].
    Paradisi F; Cristiano P; Cioffi R; Sollecito A
    G Ital Chemioter; 1979; 26(1-2):57-62. PubMed ID: 554827
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic and clinical studies with amikacin, a new aminoglycoside antibiotic.
    Lode H; Grunert K; Koeppe P; Langmaack H
    J Infect Dis; 1976 Nov; 134 SUPPL():S316-22. PubMed ID: 825589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentrations and inhibitory ratios during amikacin therapy of gram-negative infections.
    Farchione LA; Chudzik GM
    J Clin Pharmacol; 1978; 18(8-9):432-8. PubMed ID: 690253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer.
    Feld R; Valdivieso M; Bodey GP; Rodriguez V
    J Infect Dis; 1977 Jan; 135(1):61-6. PubMed ID: 401853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli.
    Mathias RG; Ronald AR; Gurwith MJ; McCullough DW; Stiver HG; Berger J; Cates CY; Fox LM; Lank BA
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-401. PubMed ID: 825590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amikacin therapy for severe gram-negative sepsis: efficacy in infections involving gentamicin-resistant organisms.
    Tally FP; Louie TJ; O'Keefe P; Gorbach SL; Bartlett JG
    J Infect Dis; 1976 Nov; 134 SUPPL():S428-32. PubMed ID: 993634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
    Leonard JM; McGee ZA; Alford RH
    Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of results of clinical trials with amikacin.
    Gooding PG; Berman E; Lane AZ; Agre K
    J Infect Dis; 1976 Nov; 134 SUPPL():S441-5. PubMed ID: 792360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aminoglycoside antibiotics from clinical viewpoint].
    Lüthy R
    Int J Clin Pharmacol Biopharm; 1975 Mar; 11(2):112-25. PubMed ID: 1095500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraventricular administration of amikacin for complicated Gram-negative meningitis and ventriculitis.
    Wirt TC; McGee ZA; Oldfield EH; Meacham WF
    J Neurosurg; 1979 Jan; 50(1):95-9. PubMed ID: 363982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary clinical trial with amikacin in chronic recurrent gram-negative bacterial infections refractory to other antimicrobial agents.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S381-3. PubMed ID: 993631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amikacin Therapy of Urinary tract infections.
    Cox CE
    J Infect Dis; 1976 Nov; 134 SUPPL():S362-8. PubMed ID: 792358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.